BioSpace News Archive

To help support cancer caregivers, the American Cancer Society (ACS) has created a Caregiver Support Video Series that can answer caregivers’ most-asked questions and address their biggest concerns

The Medical Tourism Association has successfully hosted its 12th World Medical Tourism & Global Healthcare Congress in Abu Dhabi since moving the event overseas for the first time.

Encore Medical Education (www.encoremeded.com) will publish the Official SABCS® News highlighting the key findings presented at the 42nd San Antonio Breast Cancer Symposium (SABCS®), held on December 10-14, 2019 in San Antonio, Texas, USA

Border Therapy Services and Alliance Physical Therapy Partners are pleased to announce that Texans no longer need a referral to be treated by a physical therapist.

Illinois Bone & Joint Institute (IBJI), one of the largest independent, physician-owned orthopedic practices in the United States, is excited to welcome Adam C. Young, MD, board-certified anesthesiologist and pain management physician, fellowship-trained in pain management.

Florida Blue providing Lyft ridesharing services to its ACA members

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) (“Progenics” or the “Company”), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today issued the following letter that it intends to mail to shareholders, urging shareholders to revoke any consents previously delivered to Velan Capital L.P. (“Velan”) by signing and returning Progenics’ WHITE Consent Revocation Card.

DermaVita has obtained an EUIPO finding in its favor following US pharmaceutical company Abbvie’s announcement on 25/06/2019 of its acquisition of Allergan.

Centene Corporation announced its Texas subsidiary, Superior HealthPlan, has been informed that the Texas Health and Human Services Commission intends to award a contract to continue to provide quality, integrated healthcare services to enrollees in the state’s STAR+PLUS program.

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that it will be presenting at the following regenerative medicine and investor conferences in November: